Amelie Deleporte
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 07, 2026
A case report of enduring benefit of sequential PRRT in malignant insulinoma.
Journal: EJNMMI reports
Published: October 19, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
Journal: JAMA oncology
Published: July 10, 2025
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS).
Journal: ESMO gastrointestinal oncology
Published: June 05, 2024
Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 09, 2023
Circulating DNA in the neoadjuvant setting of early stage colon cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: July 22, 2022
State of the art and future directions in the systemic treatment of neuroendocrine neoplasms.
Journal: Current opinion in oncology
Published: May 11, 2021
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
Journal: Clinical colorectal cancer
Published: April 09, 2021
Targeted agents in older patients with gastrointestinal cancers - An overview.
Journal: Journal of geriatric oncology
Published: April 07, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae.
Journal: Brain communications
Published: March 02, 2021
Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.
Journal: Cancer treatment reviews
Published: January 18, 2021
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 13, 2021
Last Updated: 09/26/2026